Clinical Trial

Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study

Study acronym: AURACCO
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the AURACCO study is to evaluate the association between the onset of tinnitus and hearing loss in patients with locally advanced head and neck cancer treated by concomitant chemoradiotherapy or exclusive radiotherapy
Protocol Amendment History 3 changes
critical Recruitment opened 2026-08-14
notable Primary completion pushed: 2025-06 -> 2027-07-09 2026-08-14
minor Completion pushed: 2026-09 -> 2029-03-09 2026-08-14
Trial Details
NCT Number NCT05946577
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Head Cancer, Neck Cancer
Enrollment 140 participants
Start Date 2023-03-09
Primary Completion 2027-07-09 (estimated)
Study Completion 2029-03-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-13